Healthcare Committee

Mission

The aim is to build stronger two way trade and investment links between NZ and USA for organisations under a healthcare umbrella beyond government level initiatives and industry organisations, working with:

•            Large multinational pharmaceutical companies who have expertise in navigating the US regulatory and market environment and who have an interest in looking at trade agreements involving NZ healthcare procurement and more specifically the role of PHARMAC and IP.

•            NZ’s highly innovative devices, digital technology, pharmaceutical and diagnostic companies whose products may be of direct interest to those companies.

The committee will meet quarterly, initially at the beginning of each year to come up with 2-3 issues the group would want to focus on and address. Results could be policy submissions and/or possible Doorknocks to Wellington. Topics could include: IP, Privacy, Procurement, Supply and Vaccine issues, Health Technology Assessment and de-identified health data.

Committee

Jyoti Rauniyar, Committee Chair - Head of Market Access, Merck Sharpe & Dohme (New Zealand) Ltd

Michael Simmonds, Director ANZ, Health Economics & Government Affairs at Boston Scientific

Ron Grasso, Head of Government Relations Australia & NZ, Thermo Fisher Scientific Australia

Craig Glover, Policy & Government Relations Lead, Assoc. Director, Merck Sharp & Dohme (New Zealand) Ltd

Penny Tucker